Characterization of intracellular pH gradients in human multidrug-resistant tumor cells by means of scanning microspectrofluorometry and dual-emission-ratio probes
R. Belhoussine et al., Characterization of intracellular pH gradients in human multidrug-resistant tumor cells by means of scanning microspectrofluorometry and dual-emission-ratio probes, INT J CANC, 81(1), 1999, pp. 81-89
Multidrug-resistant cells are believed to contain a plasma-membrane-efflux
pump which is hypothesized to expel anticancer drugs from the cytosol to th
e cell exterior. Many of these drugs are classified as weak bases whose bin
ding to intracellular targets is pH-dependent. Slight alterations in intrac
ellular pH gradients have been shown to affect accumulation, endocytosis an
d secretion of drugs. In this study, we developed a new method based on con
focal spectral imaging analysis to determine intracellular pH gradients in
sensitive and MDR tumor cells. Fluorescein isothiocyanate (FITC) and tetram
ethylrhodamine conjugated to dextran (FRD) and SNAFL-calcein-AM were used t
o determine pH in acidic compartments. Carboxy-SNARFI-AM was used to examin
e cytosolic pH. We observed that sensitive (HL60, K562, CEM and MCF7) cells
exhibit lower acidity of the subcellular organelles than that correspondin
g to drug-resistant derivatives. Moreover, results obtained with carboxy-SN
ARFI-AM show that resistant cells display a more alkaline cytosolic pH, Thi
s results in a considerably larger pH gradient between the vesicular compar
tments and the cytosol of resistant cells than of sensitive cells. The lowe
r pH gradient observed in sensitive cells may be related to a disruption in
the organization of the trans-Golgi network (TGN). In drug-resistant cells
, the organization of TGN appears compact. In addition, confocal microscopi
c analysis of cells labelled with FRD and SNAFL-calcein showed that sensiti
ve cells contain a lower number of acidified vesicles. This suggest a dimin
ished capacity of these cells to remove protonated drugs from the cytoplasm
to secretory compartments followed by their secretion through the activity
of the secretory and recycling pathways. (C) 1999 Wiley-Liss, Inc.